Review
Copyright ©The Author(s) 2020.
World J Hepatol. Sep 27, 2020; 12(9): 533-557
Published online Sep 27, 2020. doi: 10.4254/wjh.v12.i9.533
Figure 4
Figure 4 Pros and cons of various antihyperglycemic medications. NAFLD: Non-alcoholic fatty liver disease; HCC: Hepatocellular carcinoma; NASH: Nonalcoholic steatohepatitis.